WHO ICTRP trial

JPRN-jRCT2080224533

JPRN-jRCT2080224533 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCT2080224533
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase 3
Countries Japan;Asia except Japan;South America;Europe
Interventions investigational material(s) Generic name etc : INN of investigational material : Baricitinib Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s)…
Registration date Jan 30, 2019
Target size 190
Secondary IDs NCT03773965;JapicCTI-194602
Registry page jrct.niph.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations